In this review of the application of proteomics and metabolomics to kidney disease research,
we review key concepts, highlight illustrative examples, and outline future directions. The …

Diseases of the kidney are difficult to diagnose and treat. This review summarises the
definition, cause, epidemiology and treatment of some of these diseases including chronic …

Kidney research is entering an era of 'big data'and molecular omics data can provide
comprehensive insights into the molecular footprints of cells. In contrast to transcriptomics …

Metabolomics—the nontargeted measurement of all metabolites produced by the body—is
beginning to show promise in both biomarker discovery and, in the form of …

Chronic kidney disease (CKD) has emerged as a major public health problem worldwide. It
frequently progresses to end-stage renal disease, which is related to very high cost and …

Chronic kidney disease (CKD) represents a major challenge to public healthcare.
Traditional clinical biomarkers of renal function (blood urea nitrogen and serum creatinine) …

Chronic kidney disease (CKD), characterized as renal dysfunction, is recognized as a major
public health problem with high morbidity and mortality worldwide. Unfortunately, there are …

The development of new therapies for chronic diseases, such as diabetic kidney disease
(DKD), will continue to be hampered by lack of sufficient biomarkers that will provide insights …

Chronic kidney disease (CKD) is part of a number of systemic and renal diseases and may
reach epidemic proportions over the next decade. Efforts have been made to improve …

Introduction: Metabolomics could offer novel prognostic biomarkers and elucidate
mechanisms of diabetic kidney disease (DKD) progression. Via metabolomic analysis of …